About Me
The conversation around metabolic science has changed substantially over the past few years, and much of that change has been driven by growing interest in dual receptor agonist compounds. Tirzepatide occupies a particularly interesting position in this conversation because of the way it engages with multiple receptor pathways simultaneously, producing a research profile that differs meaningfully from single receptor agonist approaches.